Peter Henry Scanlon (P Scanlon, Peter Scanlon, Peter H Scanlon)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 15

Top Venues

Eye (London, England)

The British journal of ophthalmology

Journal of clinical medicine

Acta ophthalmologica

GHNHSFT

This page only lists publications with an associated author ORCID identifier.

Affiliation History

GHNHSFT

United Kingdom

Consultant :: Ophthalmology

Publications

Rebecca Jones, Irene M Stratton, Peter Henry Scanlon, Sofia Theodoropoulou
Disengagement and loss to follow-up in intravitreal injection clinics for neovascular age-related macular degeneration. Eye (London, England) (2023)
Sobha Sivaprasad, Faruque D Ghanchi, Simon P Kelly, Ajay Kotagiri, James Talks, Peter Henry Scanlon, Hellen McGoey, Andrew Nolan, Moneeb Saddiq, Jackie Napier, Peter Morgan-Warren
Evaluation of standard-of-care intravitreal aflibercept treatment practices in patients with diabetic macular oedema in the UK: DRAKO study outcomes. Eye (London, England) (2023)
Sobha Sivaprasad, Faruque D Ghanchi, Simon P Kelly, Ajay Kotagiri, James Talks, Peter Henry Scanlon, Hellen McGoey, Andrew Nolan, Moneeb Saddiq, Jackie Napier
Evaluation of care with intravitreal aflibercept treatment for UK patients with diabetic macular oedema: DRAKO study 24-month real-world outcomes. Eye (London, England) (2023)
Rebecca Jones, Irene M Stratton, Peter Henry Scanlon, Sofia Theodoropoulou
Correction to: Disengagement and loss to follow-up in intravitreal injection clinics for neovascular age-related macular degeneration. Eye (London, England) (2023)
Noemi Lois, Jonathan Alistair Cook, Ariel Wang, Stephen Aldington, Hema Mistry, Mandy Maredza, Daniel Francis McAuley, Tariq Mehmood Aslam, Clare Bailey, Ngai Victor Chong, Faruque D Ghanchi, Peter Henry Scanlon, Sobha Sivaprasad, David H W Steel, Caroline Styles, Augusto Azuara-Blanco, Lindsay Prior, Norman Waugh
Multimodal imaging interpreted by graders to detect re-activation of diabetic eye disease in previously treated patients: the EMERALD diagnostic accuracy study. Health technology assessment (Winchester, England) 25 (32) (2021)
Peter Henry Scanlon
The contribution of the English NHS Diabetic Eye Screening Programme to reductions in diabetes-related blindness, comparisons within Europe, and future challenges. Acta diabetologica 58 (4) (2021)
Peter Henry Scanlon, Clareece R Nevill, Irene M Stratton, Sonia S Maruti, Elvira L Massó-González, Sobha Sivaprasad, Clare Bailey, Michael Ehrlich, Victor Chong
Prevalence and incidence of diabetic retinopathy (DR) in the UK population of Gloucestershire. Acta ophthalmologica (2021)
James Stephen Talks, Irene M Stratton, Tunde Peto, Andrew John Lotery, Usha Chakravarthy, H Eleftheriadis, S Izadi, N Dhingra, Peter Henry Scanlon, null null
Aflibercept in clinical practice; visual acuity, injection numbers and adherence to treatment, for diabetic macular oedema in 21 UK hospitals over 3 years. Eye (London, England) (2021)
Peter Henry Scanlon, Charlotte F E Norridge, Paul H J Donachie, Quresh Mohamed
Should we still be performing macular laser for non-centre involving diabetic macular oedema? Results from a UK centre. Eye (London, England) (2021)
John J Smith, David M Wright, Irene M Stratton, Peter Henry Scanlon, Noemi Lois
Testing the performance of risk prediction models to determine progression to referable diabetic retinopathy in an Irish type 2 diabetes cohort. The British journal of ophthalmology (2021)
Clareece R Nevill, Irene M Stratton, Sonia S Maruti, Elvira L Massó-González, Sobha Sivaprasad, Clare Bailey, Michael Ehrlich, Victor Chong, Peter Henry Scanlon
Epidemiology of moderately severe and severe non-proliferative diabetic retinopathy in South West England. Eye (London, England) (2021)
Sobha Sivaprasad, Faruque D Ghanchi, Simon P Kelly, Ajay Kotagiri, James Stephen Talks, Peter Henry Scanlon, Hellen McGoey, Andrew Nolan, Moneeb Saddiq, Jackie Napier, null null
Evaluation of standard of care intravitreal aflibercept treatment of diabetic macular oedema treatment-naive patients in the UK: DRAKO study 12-month outcomes. Eye (London, England) (2021)
Cristina Hernandez, Massimo Porta, Francesco Bandello, Jakob Grauslund, Simon Peter Harding, Stephen J Aldington, Catherine Egan, Ulrik Frydkjaer-Olsen, José García-Arumí, Jonathan Gibson, Gabriele E Lang, Rosangela Lattanzio, Pascale Massin, Edoardo Midena, Berta Ponsati, Luísa Ribeiro, Peter Henry Scanlon, José Cunha-Vaz, Rafael Simò
The Usefulness of Serum Biomarkers in the Early Stages of Diabetic Retinopathy: Results of the EUROCONDOR Clinical Trial. Journal of clinical medicine 9 (4) (2020)
Peter Heydon, Catherine Egan, Louis Bolter, Ryan Chambers, John Anderson, Steve Aldington, Irene M Stratton, Peter Henry Scanlon, Laura Webster, Samantha Mann, Alain du Chemin, Christopher G Owen, Adnan Tufail, Alicja Regina Rudnicka
Prospective evaluation of an artificial intelligence-enabled algorithm for automated diabetic retinopathy screening of 30 000 patients. The British journal of ophthalmology 105 (5) (2020)
Jose Leal, Ramon Luengo-Fernandez, Irene M Stratton, Angela Dale, Katerina Ivanova, Peter Henry Scanlon
Cost-effectiveness of digital surveillance clinics with optical coherence tomography versus hospital eye service follow-up for patients with screen-positive maculopathy. Eye (London, England) 33 (4) (2018)

Peter Henry Scanlon.css-eqlu8i{font-size:small;padding-left:4px;} (P Scanlon, Peter Scanlon, Peter H Scanlon)

Publication Activity (10 Years)

Top Topics

Top Venues

Peter Henry Scanlon (P Scanlon, Peter Scanlon, Peter H Scanlon)